Thus, prolactin, the major trophic cytokine for the breast, is known to rapidly induce SOCS-1–3 and CIS, and this results in loss of sensitivity to subsequent prolactin challenge (Tam et al, 2001). This evidence concerns the gene PRL and in situ carcinoma.